Kuros Biosciences AG (0RHR.L) Stock Price
CHF27.11 0%
to add to portfolio
AI Score

-
Alternative
7 -
Fundamental
7 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Kuros Biosciences AG, AI stock picks, stock alerts and much more.
0RHR.L AI Stock Analysis
AI stock analysis for 0RHR.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Kuros Biosciences AG (0RHR.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Kuros Biosciences AG (0RHR.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Kuros Biosciences AG (0RHR.L), currently trading at CHF27.11, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0RHR.L

-
Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development of biopharmaceutical products for tissue repair and bone regeneration in the United States, the European Union, and internationally.
-
Symbol
0RHR.L
-
Market
LSE
-
Industry
Biotechnology
-
Market Cap
1B
Similar Stocks
![]() |
Codexis 0I0X.L |
$3 5.5% |
5 |
![]() |
Oxford Nanopore Technologies plc ONT.L |
£208.2 1.3% |
7 |
![]() |
Sareum Holdings SAR.L |
£22 8.3% |
5 |
![]() |
Viridian Therapeutics 0K1R.L |
$19.19 8.5% |
6 |
![]() |
Avacta Group Plc AVCT.L |
£49 1% |
4 |
News
No news articles.
0RHR.L Alternative Data
Web Traffic
Kuros Biosciences AG receives an estimated 0 monthly visitors to kuros.ch.
-
Web Traffic
0
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
Instagram Followers
Kuros Biosciences AG has 486 Instagram Followers on its main Instagram account, down by -0.4% over the last month.
-
Instagram Followers
486
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
1.7%
Youtube Subscribers
Kuros Biosciences AG has 197 subscribers on its main Youtube channel, up by 3.7% over the last month.
-
Youtube Subscribers
197
-
Daily Change
0%
-
1 Month Change
3.7%
-
3 Month Change
10.1%
Reddit Mentions
Kuros Biosciences AG has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
9,769 are following Kuros Biosciences AG on LinkedIn, up by 1.6% over the last month.
-
LinkedIn Followers
9769
-
Daily Change
1.6%
-
1 Month Change
1.6%
-
3 Month Change
9.3%
LinkedIn Employees
According to LinkedIn, Kuros Biosciences AG has 163 employees, up by 3.8% over the last month.
-
LinkedIn Employees
163
-
Daily Change
3.8%
-
1 Month Change
3.8%
-
3 Month Change
12.4%
Business Outlook
According to employee reviews, the business outlook among employees at Kuros Biosciences AG is 67 out of 100 (bullish).
-
Business Outlook
67
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Kuros Biosciences AG was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0RHR.L Financials
0RHR.L Key Metrics
-
Total Revenue
CHF43.7M
-
Net Income
-CHF4.1M
-
Earnings per Share
-CHF0.11
-
Free cash flow
CHF3M
-
EBITDA
-CHF2.3M
-
EBITDA Ratio
-0.0536249
-
Total Assets
CHF84.5M
0RHR.L 2-year Revenue & Income
0RHR.L 2-year Free Cash Flow
0RHR.L Technicals
0RHR.L SMA
0RHR.L RSI
FAQ
What's the current price of Kuros Biosciences AG (0RHR.L) Stock?
The price of an Kuros Biosciences AG (0RHR.L) share is CHF27.11.
What's the market cap of Kuros Biosciences AG?
The current market cap of Kuros Biosciences AG is 1B.
Should I buy or sell 0RHR.L?
Kuros Biosciences AG shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Kuros Biosciences AG is better viewed as a hold or accumulate position while waiting for further developments.
Is Kuros Biosciences AG a good investment?
The current analysis of Kuros Biosciences AG's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Kuros Biosciences AG's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Kuros Biosciences AG (0RHR.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Kuros Biosciences AG stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Kuros Biosciences AG (0RHR.L) that investors often compare it to?
Kuros Biosciences AG (0RHR.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Viridian Therapeutics and Avacta Group Plc.
What is the forecast for Kuros Biosciences AG's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Kuros Biosciences AG's stock price to be around CHF28.74 in 2026. Starting from the current price of CHF27.11, this represents a 6% change in price, indicating a bullish outlook for the stock.
How to buy Kuros Biosciences AG (0RHR.L) Stock?
Kuros Biosciences AG stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Kuros Biosciences AG shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.